Antioxidant Intervention in NAFLD: Astaxanthin and Kokum Modulate Redox Status and Lysosomal Degradation
Molecules · 2026
DOI: 10.3390/molecules31020321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Natalia Ksepka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Nutrigenomics, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Postępu 36a, Jastrzębiec, …. Hauptthemen laut MEDLINE: Antioxidants, Non-alcoholic Fatty Liver Disease, Lysosomes. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is a major metabolic disorder characterized by hepatic lipid accumulation, oxidative stress, and disturbance of lysosomal degradation. Central to these processes is glutathione (GSH), a key antioxidant regulating redox balance and cellular homeostasis. This study aimed to evaluate the therapeutic potential of two dietary antioxidants—astaxanthin and Garcinia indica (kokum)—in modulating hepatic redox status, lysosomal function, and metabolic gene expression in a murine model of diet-induced NAFLD. A total of 120 male Swiss Webster mice were allocated into control and steatotic groups, followed by a 90-day supplementation period with astaxanthin, kokum, or their combination. Liver tissue was collected post-supplementation for biochemical, antioxidant, and qRT-PCR analyses. Outcomes included lysosomal enzymes activities, superoxide dismutase (SOD), GSH, vitamin C, total polyphenols, DPPH radical-scavenging activity, and total antioxidant capacity (TAC). NAFLD induced marked oxidative stress, lysosomal overactivation, and alteration of antioxidant-related gene expression. Combined supplementation restored GSH, enhanced TAC, reduced lysosomal stress markers, and significantly upregulated nuclear factor erythroid 2-related factor 2 (Nfe2l2) while downregulating fatty acid synthase (FASN) and partially rescuing lipoprotein lipase (LpL). Correlation analyses revealed strong associations between antioxidant capacity, lysosomal function, and transcriptional regulation, supporting the therapeutic relevance of combined antioxidant therapy for concurrent redox and lysosomal dysregulation in NAFLD. These findings underscore the therapeutic potential of targeting redox and cellular degradation pathways with antioxidant-based interventions to re-establish hepatic metabolic balance in NAFLD and related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Nutrigenomics, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Postępu 36a, Jastrzębiec, 05-552 Magdalenka, Poland.
- Department of Veterinary Medicine and Animal Sciences-DIVAS, University of Milan, Via dell'Università 6, 26900 Lodi, Italy.
- Division of Medical Biology, Institute of Biology, University of Jan Kochanowski, 25-406 Kielce, Poland.
- Department of General, Gastroenterology, and Oncologic Surgery, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.
ORCID-Profile: Natalia Ksepka, Natalia Kuzia, Sara Frazzini, Luciana Rossi, Małgorzata Łysek-Gładysińska, Michał Ławiński, Artur Jóźwik
Zitieren
APA
Ksepka, N., Kuzia, N., Frazzini, S., Rossi, L., Łysek-Gładysińska, M., Ławiński, M., & Jóźwik, A. (2026). Antioxidant Intervention in NAFLD: Astaxanthin and Kokum Modulate Redox Status and Lysosomal Degradation. Molecules. https://doi.org/10.3390/molecules31020321
Vancouver
Ksepka N, Kuzia N, Frazzini S, Rossi L, Łysek-Gładysińska M, Ławiński M, et al. Antioxidant Intervention in NAFLD: Astaxanthin and Kokum Modulate Redox Status and Lysosomal Degradation. Molecules. 2026. doi:10.3390/molecules31020321
BibTeX
@article{Ksepka2026,
author = {Ksepka, Natalia and Kuzia, Natalia and Frazzini, Sara and Rossi, Luciana and Łysek-Gładysińska, Małgorzata and Ławiński, Michał and Jóźwik, Artur},
title = {Antioxidant Intervention in NAFLD: Astaxanthin and Kokum Modulate Redox Status and Lysosomal Degradation},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31020321}
}
EUVIMED